Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes
Table 3
The median and interquartile range of serum concentration of ENA6 profile in the healthy subjects and in the SLE patients.
Marker
Status
Percentiles
25
50
75
values
ENA 6 SS-A
Healthy controls
1.20
3.55
5.75
SLE patients
2.85
11.70
183.51
ENA 6 SS-B
Healthy controls
1.45
3.10
5.90
SLE patients
1.71
6.64
46.32
ENA 6 Sm
Healthy controls
0.60
1.65
2.625
SLE patients
2.27
19.93
135.95
Sm/RNP
Healthy controls
0.50
1.20
2.80
SLE patients
17.70
56.61
166.96
Jo-1
Healthy controls
0.00
0.205
0.80
SLE patients
1.40
2.22
4.79
SCL 70
Healthy controls
0.00
0.155
0.28
SLE patients
0.71
1.10
3.33
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
